Incidence of allopurinol‐induced severe cutaneous adverse drug reaction in Malaysia-Reference-Cited by-同舟云学术

Incidence of allopurinol‐induced severe cutaneous adverse drug reaction in Malaysia

Published:2022-04-04 Issue:8 Volume:88 Page:3782-3788
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Ng Wei Leik¹^ORCID,Lim Kheng Seang²,Hariraj Vidhya³,Lee Sing Chet³,Wo Wee Kee³,Ramli Azuana³,Lai Pauline Siew Mei¹,Fong Si Lei²,Lim Jing Ran¹

Affiliation:

1. Department of Primary Care Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

2. Division of Neurology, Department of Medicine, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

3. Pharmacovigilance Section, Centre of Compliance and Quality Control National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15327

Reference39 articles.

1. 2020 American College of Rheumatology Guideline for the Management of Gout

2. Gout

3. LeeCK A.M.A. LeeYY ChangCC BabaR Allopurinol Induced Adverse Cutaneous Drug Reactions (ACDRs): A Review of MADRAC (Malaysian Adverse Drug Reaction Advisory Committee) Report from 2000–2009.2012: Malaysia.

4. A 10‐years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia;Loo CH;Med J Malaysia,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of hydrogen-rich water on blood uric acid in patients with hyperuricemia: A randomized placebo-controlled trial;Heliyon;2024-08

2. Implementing HLA-B*58:01 testing prior to allopurinol initiation in Malaysian primary care setting: A qualitative study from doctors’ and patients’ perspective;PLOS ONE;2024-01-11

3. Hepatic Safety of Febuxostat and Allopurinol for Gout Patients: A Systematic Review of Randomized Controlled Trial;Therapeutics and Clinical Risk Management;2023-09

4. A Mobile App Leveraging Citizenship Engagement to Perform Anonymized Longitudinal Studies in the Context of COVID-19 Adverse Drug Reaction Monitoring: Development and Usability Study;JMIR Human Factors;2022-11-04